Your browser doesn't support javascript.
loading
Transcription factor SP1 and oncoprotein PPP1R13L regulate nicotine-induced epithelial-mesenchymal transition in lung adenocarcinoma via a feedback loop.
Zhang, Hongchao; Zhang, Guopei; Zhang, Jingyue; Xiao, Mingyang; Cui, Su; Wu, Shengwen; Jin, Cuihong; Yang, Jinghua; Lu, Xiaobo.
Afiliación
  • Zhang H; Department of Toxicology, School of Public Health, China Medical University, Shenyang 110122, People's Republic of China.
  • Zhang G; Department of Toxicology, School of Public Health, China Medical University, Shenyang 110122, People's Republic of China.
  • Zhang J; Department of Toxicology, School of Public Health, China Medical University, Shenyang 110122, People's Republic of China.
  • Xiao M; Department of Toxicology, School of Public Health, China Medical University, Shenyang 110122, People's Republic of China.
  • Cui S; Department of Thoracic Surgery Ward 2, The First Hospital of China Medical University, Shenyang 110002, People's Republic of China.
  • Wu S; Department of Toxicology, School of Public Health, China Medical University, Shenyang 110122, People's Republic of China.
  • Jin C; Department of Toxicology, School of Public Health, China Medical University, Shenyang 110122, People's Republic of China.
  • Yang J; Department of Toxicology, School of Public Health, China Medical University, Shenyang 110122, People's Republic of China.
  • Lu X; Department of Toxicology, School of Public Health, China Medical University, Shenyang 110122, People's Republic of China. Electronic address: xblu@cmu.edu.cn.
Biochem Pharmacol ; 206: 115344, 2022 12.
Article en En | MEDLINE | ID: mdl-36372331
Tobacco remains the most common environmental carcinogen leading to the occurrence and development of lung cancer. Nicotine, a tumor promoter in cigarette smoke, has been shown to induce epithelial-mesenchymal transition (EMT), a cellular program required for the invasion and metastasis in tumor cells. Specificity Protein 1 (SP1) is a well-characterized transcription factor that can regulate the EMT process via transcriptionally activating E-cadherin expression. Protein Phosphatase 1 Regulatory Subunit 13 Like (PPP1R13L) is a newly identified oncoprotein previously reported to inhibit the transcriptional activity of SP1 via a direct protein-protein interaction. To reveal the underlying implication of the interconnections between PPP1R13L and SP1 in the nicotine-induced EMT process, the present study established an EMT cell model of lung cancer using 1 µM of nicotine, a dose close to human exposure, in which an alternate fluctuation in the expression of PPP1R13L and SP1 was captured. Subsequently, the direct inhibition of SP1 by PPP1R13L was demonstrated to be a critical mechanism underlying the involvement of PPP1R13L in the nicotine-induced EMT process. More interestingly, SP1 was further shown to transcriptionally activate PPP1R13L expression in a feedback manner. In addition, PPP1R13L and SP1 expression was found to be closely associated with the clinicopathological characteristics of lung cancer patients. Here we proposed a novel feedback regulation mechanism, in which SP1 may transcriptionally activate the PPP1R13L gene expression in the early stage of lung cancer to promote tumor growth, while the accumulation of PPP1R13L drives tumor invasion and metastasis by direct repression of SP1. Thus, this unique feedback loop between PPP1R13L and SP1 may play a vital role in chemical carcinogenesis and serve as a potential intervention target for lung cancer progression attributable to cigarette smoking.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biochem Pharmacol Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Biochem Pharmacol Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido